secondary hypertension
Jump to navigation
Jump to search
Etiology
- kidney disease
- chronic renal failure, (90% of patients with ESRD)
- renal artery stenosis
- adrenal gland disease
- obstructive sleep apnea[2][3][4]
- pharmaceutical agents
- foods & beverages
Laboratory
- indications for laboratory testing[1]
- young age
- no family history
- no risk factors
- rapid onset of hypertension
- endocrine disease
Management
- see resistant hypertension or specific etiology
More general terms
References
- ↑ 1.0 1.1 Medical Knowledge Self Assessment Program (MKSAP) 15, 16. 18. American College of Physicians, Philadelphia 2009, 2012, 2018.
- ↑ 2.0 2.1 Moser M, Setaro JF. Clinical practice. Resistant or difficult-to-control hypertension. N Engl J Med 2006 Jul 28; 355:385. PMID: https://www.ncbi.nlm.nih.gov/pubmed/16870917
- ↑ 3.0 3.1 Myat A et al. Resistant hypertension. BMJ 2012 Nov 22; 345:e7473. PMID: https://www.ncbi.nlm.nih.gov/pubmed/23169802
- ↑ 4.0 4.1 Calhoun DA et al. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 2008 Apr 9; 51:1403. PMID: https://www.ncbi.nlm.nih.gov/pubmed/18391085
- ↑ Aronow WS. Drug-induced causes of secondary hypertension. Ann Transl Med. 2017;5(17):349 PMID: https://www.ncbi.nlm.nih.gov/pubmed/28936443 PMCID: PMC5599270 Free PMC article https://atm.amegroups.com/article/view/15358/16263
- ↑ Foy MC, Vaishnav J, Sperati CJ. Drug-induced hypertension. Endocrinol Metab Clin North Am. 2019;48(4):859-873 PMID: https://www.ncbi.nlm.nih.gov/pubmed/31655781 https://www.sciencedirect.com/science/article/abs/pii/S0889852919300672